Follow Us
- Loans
- All on EMI
- Bajaj Mall
- Card
- Investments
- Insurance
- Payments
- Offers
- Services
- About Bajaj Finserv
JENBURPH
Today’s low
Today’s high
52 week low
52 week high
Particulars | Dec 25 (₹ value in crores) |
|---|---|
Revenue | ₹43.02 |
Operating expense | ₹36.55 |
Net income | ₹5.93 |
Net profit margin | 13.78% |
Earning per share | ₹13.44 |
EBITDA | ₹9.25 |
Effective tax rate | 28.55% |
| Company name | Price | P/E | P/B | Market cap | 52 week low/high |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | ₹25.41 | 12.46 | 1.31 | ₹194.73 | ₹23.12 / ₹53.83 |
| BLISS GVS PHARMA LTD | ₹183.50 | 17.71 | 1.71 | ₹1,941.23 | ₹105.05 / ₹195.85 |
| CIPLA LTD | ₹1,330.80 | 22.61 | 3.26 | ₹1,07,499.45 | ₹1,283.00 / ₹1,672.20 |
| FERMENTA BIOTECH LIMITED | ₹328.25 | 8.62 | 2.47 | ₹966.07 | ₹219.00 / ₹449.00 |
| GLAXOSMITHKLINE PHARMA LT | ₹2,485.85 | 44.18 | 24.66 | ₹42,111.80 | ₹1,968.00 / ₹3,515.95 |
| Company name | Price | P/E | P/B | Market cap | 52 week low/high |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | ₹25.41 | 12.46 | 1.31 | ₹194.73 | ₹23.12 / ₹53.83 |
| BLISS GVS PHARMA LTD | ₹183.50 | 17.71 | 1.71 | ₹1,941.23 | ₹105.05 / ₹195.85 |
| CIPLA LTD | ₹1,330.80 | 22.61 | 3.26 | ₹1,07,499.45 | ₹1,283.00 / ₹1,672.20 |
| FERMENTA BIOTECH LIMITED | ₹328.25 | 8.62 | 2.47 | ₹966.07 | ₹219.00 / ₹449.00 |
| GLAXOSMITHKLINE PHARMA LT | ₹2,485.85 | 44.18 | 24.66 | ₹42,111.80 | ₹1,968.00 / ₹3,515.95 |
Parent Organisation
NSE Symbol
Founded
| Dividend date | Dividend amount | Dividend type | Record date | Instrument type |
|---|---|---|---|---|
| 11 Jul 2025 | 18 | Final | 11 Jul 2025 | Equity shares |
| 23 Jul 2024 | 15.3 | Final | 24 Jul 2024 | Equity shares |
| 19 Jul 2023 | 14.4 | Final | 20 Jul 2023 | Equity shares |
| 21 Jul 2022 | 12 | Final | 23 Jul 2022 | Equity shares |
| 30 Aug 2021 | 10.2 | Final | 01 Sept 2021 | Equity shares |
| 18 Mar 2020 | 8.1 | Interim | 19 Mar 2020 | Equity shares |
| 22 Jul 2019 | 10.2 | Final | 24 Jul 2019 | Equity shares |
| 23 Jul 2018 | 6 | Final | 25 Jul 2018 | Equity shares |
| 27 Mar 2018 | 3 | Interim | 28 Mar 2018 | Equity shares |
| 21 Jul 2017 | 8.1 | Final | 25 Jul 2017 | Equity shares |
| 19 Jul 2016 | 0.9 | Final | 21 Jul 2016 | Equity shares |
| 17 Mar 2016 | 6.3 | Interim | 18 Mar 2016 | Equity shares |
| 31 Aug 2015 | 6.3 | Final | 02 Sept 2015 | Equity shares |
| 03 Sept 2014 | 5.1 | Final | 05 Sept 2014 | Equity shares |
| 18 Sept 2013 | 4.2 | Final | 20 Sept 2013 | Equity shares |
| 23 Jul 2012 | 3.5 | Final | 25 Jul 2012 | Equity shares |
| 21 Jul 2011 | 3.5 | Final | 23 Jul 2011 | Equity shares |
| 21 Jul 2010 | 3 | Final | 23 Jul 2010 | Equity shares |
| 23 Jul 2009 | 1.8 | Final | 25 Jul 2009 | Equity shares |
| 23 Jul 2008 | 1.25 | Final | 25 Jul 2008 | Equity shares |
| 18 Jul 2007 | 1.25 | Final | 20 Jul 2007 | Equity shares |
| 10 Aug 2005 | 0 | Final | 12 Aug 2005 | Equity shares |
LOYAL TEXTILE MILLS LTD.
GORANI INDUSTRIES LTD.
NIRAJ ISPAT IND LTD
STRATMONT INDUSTRIES LIMITED
ITC LTD
KOTAK MAHINDRA BANK LTD
HINDUSTAN UNILEVER LTD.
BHARTI AIRTEL LIMITED
HDFC LIFE INS CO LTD
TATA CONSULTANCY SERV LT
TECH MAHINDRA LIMITED
BAJAJ AUTO LIMITED
As of 06/02/2026, at 15:30 PM, the Jenburkt Pharmaceuticals Ltd. share price stands at ₹1063.85.
As of 06/02/2026, the market cap of Jenburkt Pharmaceuticals Ltd. stands at ₹469.50 Cr.
The PE and PB ratios of Jenburkt Pharmaceuticals Ltd. is 14.48 ratio and 414.38 ratio as of 06/02/2026.
<p>The 52 week high and low of Jenburkt Pharmaceuticals Ltd. is ₹1410 and ₹936.7 as of 06/02/2026.<br /></p>
<p>You can easily buy Jenburkt Pharmaceuticals Ltd. shares on the <b>Bajaj Broking</b> platform by opening a Demat account and verifying your KYC documents online. There are no account opening charges for a Demat account with Bajaj Broking.<br></p>
A company’s share price is determined by supply and demand dynamics in the stock market. Factors influencing it include the company’s financial performance, earnings growth, revenue, and profitability, as well as broader economic conditions, market sentiment, and investor perception. Other determinants include sector trends, government policies, interest rates, and global events. Positive news or growth prospects can drive demand and raise the share price, while negative developments can push it lower. Analysts’ recommendations, institutional buying or selling, and technical factors such as trading volume also influence price movements. Ultimately, the share price reflects the market’s collective view of a company’s current and future value.
The “last sale” is the most recent price at which a stock, like Jenburkt Pharmaceuticals Ltd., was traded. The “bid” price represents the highest price buyers are willing to pay, while the “ask” price is the lowest price sellers are ready to accept. The difference between the bid and ask is known as the spread. Monitoring these prices helps investors understand market sentiment and liquidity. For example, a narrow spread indicates high liquidity and active trading, while a wide spread may suggest lower activity or higher volatility. These metrics are crucial for executing timely buy or sell orders in the stock market.
Share price charts display the historical price movement of Jenburkt Pharmaceuticals Ltd., helping investors analyse trends, patterns, and potential entry or exit points. Charts typically show candlestick patterns, line graphs, or bar charts, representing open, high, low, and close prices. Key indicators include moving averages, support and resistance levels, and trading volume. Candlestick patterns can reveal bullish or bearish trends, while volume confirms the strength of price movements. Investors can use charts for technical analysis to assess momentum, predict short-term fluctuations, or complement fundamental analysis for long-term decisions. Understanding trends over daily, weekly, or monthly periods helps in making informed trading and investment choices.
Volatility measures the degree of price fluctuations of a stock over time. High volatility indicates that Jenburkt Pharmaceuticals Ltd. share price can experience large swings in short periods, while low volatility suggests stable prices. Factors causing volatility include market sentiment, earnings announcements, global events, economic indicators, and industry news. High volatility can create opportunities for traders to profit from rapid price changes but also increases risk for long-term investors. Understanding volatility helps investors manage risk, set stop-loss limits, and determine the appropriate investment horizon based on their risk tolerance.
*Disclaimer for Bajaj Finance Limited (‘BFL’):
Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.
When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.
BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."
**Disclaimer: For Bajaj Financial Securities Limited
Investments in the securities market are subject to market risk, read all related documents carefully before investing.
Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.
Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)
This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.
Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.
For more disclaimer, check here: https://www.bajajbroking.in/disclaimer
Powered by Bajaj Financial Securities Limited (Bajaj Broking)
Pay EMIs
Do not call
Download the app
